The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting

BACKGROUND: Depending on the site of irradiation, about 40-80% of patients undergoing radiotherapy (RT) will experience nausea and/or vomiting. The current study aimed to investigate the efficacy of ondansetronas as a single agent and with a combination to aprepitant on preventing RT-induced nausea...

Descripción completa

Detalles Bibliográficos
Autores principales: Emami, Hamid, Hematti, Simin, Saeidian, Seyed Masoud, Feizi, Awat, Taheri, Shahin, Adeli, Pourya, Mahmoudi, Golshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468446/
https://www.ncbi.nlm.nih.gov/pubmed/26109986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468446/
https://www.ncbi.nlm.nih.gov/pubmed/26109986

Ejemplares similares